Bioluminescent assays for ADMET

Bibliography

• Lin J, Sahakian DC, De Morais SMF, Xu JJ, Polzer RJ, Winter SM. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Cur Top Med Chem 2003;3:1125-54
   PubMed Web of Science ®Google Scholar
• Weinkers LC, Heath GH. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005;4:825-33
   PubMed Web of Science ®Google Scholar
• Branchini BR, Magyar RA, Murtiashaw MH, Anderson SM, Zimmer M. Site-directed mutagenesis of histidine 245 in firefly luciferase: a proposed model of the active site. Biochemistry 1998;37(44):15311-19
   PubMed Web of Science ®Google Scholar
• Seliger HH, McElroy WD. Spectral emission and quantum yield of firefly bioluminescence. Arch Bioch Biophys 1960;88:136-41
   PubMed Web of Science ®Google Scholar
• Cali JJ, Ma D, Sobol M, et al. Luminogenic cytochrome P450 assays. Exp Opin Drug Metab Toxicol 2006;2(4):629-45
   PubMed Web of Science ®Google Scholar
• Sobol M, Ma D, Cali JJ. P450-glo CYP3A4 biochemical and cell-based assays. Promega Notes 2007;98:15-18
   Google Scholar
• Valley MP, Zhou W, Hawkins EM, et al. A bioluminescent assay for monoamine oxidase activity. Anal Bioch 2006;359:238-46
   PubMed Web of Science ®Google Scholar
• Technical Resources, Promega Corp. website, see GSH-Glo Glutathione Assay, Technical Bulletin 369. Available at: URL:www.promega.com/ [Accessed October 2007]
   Google Scholar
• O'Brien MA, Daily WJ, Hesselberth PE, et al. Homogeneous, bioluminescent protease assays: Caspase-3 as a model. J Biomol Screen 2005;10:137-48
   PubMed Web of Science ®Google Scholar
• Arnone MI, Dmochowski IJ, Gache C. Using reporter genes to study cis-regulatory elements. Methods Cell Biol 2004;74:621-52
   PubMed Web of Science ®Google Scholar
• Lin JH. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 2006;23(6):1089-116
   PubMed Web of Science ®Google Scholar
• Madan A, Graham RA, Carroll KM, et al. Effects of prototypical enzyme inducers on cytochrome P450 expression in cultured hepatocytes. Drug Metab Dispos 2003;31(4):421-31
   PubMed Web of Science ®Google Scholar
• Willson TM, Kliewer SA. PXR, CAR and drug metabolism. Nat Rev Drug Discov 2002;1:259-66
   PubMed Web of Science ®Google Scholar
• Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Bioch Pharm 1999;59:65-85
   Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, Vilarem MJ. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear receptors and steroid receptors. Biochim Biophys Acta 2003;1619:242-53
   Google Scholar
• Quattrochi LC, Guzelian PS. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 2001;29(5):615-22
   PubMed Web of Science ®Google Scholar
• Savas U, Hsu MH, Johnson EF. Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch Bioch Biophys 2003;409(1):212-20
   PubMed Web of Science ®Google Scholar
• Ferguson SS, Chen Y, Lecluyse EL, Goldstein JA. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear recptor 4-. Mol Pharmacol 2005;68(3):747-57
   PubMed Web of Science ®Google Scholar
• Chen Y, Ferguson SS, Negisgi M, Goldstein JA. Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promotor. Mol Pharmacol 2003;64(2):316-24
   PubMed Web of Science ®Google Scholar
• Cerveny L, Svecova L, Anzenbacherova E, et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 2007;35(7):1032-41
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47(5):566-78
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharm 1999;56:1329-39
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, et al. The human nuclear xenobiotics receptor PXR: structural determinants of directed promiscuity. Science 2001;292:2329-33
   PubMed Web of Science ®Google Scholar
• Zhu Z, Puglisi J, Connors D, et al. Use of cryopreserved transfected cells in high-throughput pregnane X receptor transactivation assay. J Biomol Screen 2007;12(2):248-54
   PubMed Web of Science ®Google Scholar
• Lim H-K, Duczak N, Brougham L, Elliot M, Patel K, Chan K. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes. Drug Metab Dispos 2005;33:1211-19
   PubMed Web of Science ®Google Scholar
• Hall MP, Gruber MG, Hannah RR, Jennens-Clough ML, Wood KV. Stabilization of firefly luciferase using directed evolution. In: Bioluminescence and Chemiluminescence: Perspectives for the 21st Century. Rode A, Pazzagli M, Kricka LJ, Stanley PE (Eds), John Wiley & Sons, Chichester; 1998. p. 392-5
   Google Scholar
• Kitayama A, Yoshizaka H, Ohmiya Y, Ueda H, Nagamune T. Creation of a thermostable firefly luciferase with pH-insensitive luminescent color. Photochem Photobio 2003;77(3):333-8
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Tox 1992;22(1):1-21
   PubMed Web of Science ®Google Scholar
• Furge LL, Guengerich FP. Cytochrome P450 enzymes in drug metabolism and chemical toxicity. Bioch Mol Biol Ed 2006;34(2):66-74
   PubMed Web of Science ®Google Scholar
• Technical Resources, Promega Corp. website, see P450-Glo Assays, Technical Bulletin 325. Available at: URL: www.promega.com [Accessed August 2007]
   Google Scholar
• Technical Resources, Promega Corp. website, see P450-Glo Screening Systems, Technical Bulletin 340. Available at: URL:www.promega.com [Accessed August 2007]
   Google Scholar
• Yuey MF, Kawahar M, Raucy J. High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line. Drug Metab Dispos 2005;33(1):38-48
   PubMed Web of Science ®Google Scholar
• Westerink MA, Schoonen WGEJ. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 2007;21:1581-91
   PubMed Web of Science ®Google Scholar
• Anderson GR, Hasan A, Yin H, Qadri I, Quattrochi LC. Regulation of the CYP1A1 gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin but not by -naphthoflavone or 3-methylcholanthrene is altered in hepatitis c virus replicon-expressing cells. Mol Pharm 2006;70(3):1062-70
   Web of Science ®Google Scholar
• Wang K, Mendy AJ, Dai G, Luo H-R, He L, Wan Y-JY. Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in huh7 human hepatoma cells. Toxicol Sci 2006;92(1):51-60
   PubMed Web of Science ®Google Scholar
• Weaver R, Graham KS, Beattie IG, Rob J, Rilet RJ. Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation. Drug Metab Dispos 2003;31(7):955-66
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Suzuki A, Kohno Y. Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. Drug Metab Pharmacokin 2002;17(5):437-48
   PubMedGoogle Scholar
• Crespi CL, Miller VP, Penman BW. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Bioch 1997;248:188-90
   PubMed Web of Science ®Google Scholar
• Moody GC, Griffin SJ, Mather AN, Mcginnity DF, Riley RJ. Fully automated analysis of activities catalyzed by the major human liver cytochrome P450 (cyp) enzymes: assessment of human cyp inhibition potential. Xenobiotica 1999;29(1):53-75
   PubMed Web of Science ®Google Scholar
• Di Marco A, Cellucci A, Chaudhary A, Massimiliano F, Laufer R. Hig-throughput radiometric CYP2C19 inhibition assay using tritiated (S)-mephenytoin. Drug Metab Dispos 2007;35(10):1737-43
   PubMed Web of Science ®Google Scholar
• Nomeir AA, Ruegg C, Shoemaker M, et al. Inhibition of CYP3A4 in a rapid microtiter plate assay using recombinant enzyme and in human liver microsomes using conventional substrates. Drug Metab Dispos 2001;29(8):748-53
   PubMed Web of Science ®Google Scholar
• Geha RM, Rebrin I, Chen K, Shih JC. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J Biol Chem 2001;276(13):9877-82
   PubMed Web of Science ®Google Scholar
• Komoroski BJ, Zhang S, Cai H, et al. Induction and inhibition of cytochromes P450 by the St. John's Wort constituent hyperforin in human hepatocytes cultures. Drug Metab Dispos 2004;32(5):512-18
   PubMed Web of Science ®Google Scholar
• Lu C, Li AP. Species comparison in P450 induction: effects of dexamethosone, omeprazole, and rifampicin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem-Biol Interac 2001;134:419-38
   Google Scholar
• Mohutsky MA, Petullo DM, Wrighton SA. The use of a substrate cassette strategy to improve the capacity and throughput of cytochrome P450 induction studies in human hepatocytes. Drug Metab Dispos 2005;33(7):920-3
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker J, Ozaki K, Zoleta V. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxol Sci 2004;79:233-41
   PubMed Web of Science ®Google Scholar
• Madan A, Dehaan R, Mudra D, Carroll K, Lecluyse E, Parkinson A. Effect of cryopreservation on cytochrome P450 enzyme induction in cultured rat hepatocytes. Drug Metab Dispos 1999;27(3):327-35
   PubMed Web of Science ®Google Scholar
• Stresser DM, Turner SD, Ackermann JM, Miller VP, Crespi CL. Fluorometric cytochromes P450 2C8, 2C9, and 2C19 inhibition assays: testing the one substrate paradigm. Poster. Available at: URL: www.bdbiosciences.com/discovery_labware/gentest/products/pdf/post_015.pdf
   Google Scholar
• Stresser DM, Blanchard AP, Turner SD, et al. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 2000;28(12):1440-8
   PubMed Web of Science ®Google Scholar
• Nakamura K, Hanna IH, Cai H, Nishimura Y, Williams KM, Guengerich FP. Coumarin substrates for cytochrome P450 2D6 fluorescence assays. Analyt Bioch 2001;292:280-6
   PubMed Web of Science ®Google Scholar
• Cali JJ, Sobol M, Ma D, Good T, Liu D. P450-Glo CYP2C19 and CYP2D6 assays. Cell Notes 2006;14:20-4
   Google Scholar
• Worzella T, Larson B, Cali J, Gallagher A, Matthews E. Miniturizing luminescent P450-Glo assays for HTS. Cell Notes 2004;10:6-8
   Web of Science ®Google Scholar
• Cali JJ, Sobol M, Ma D. Screen for cytochrome P450 activity using luminescent assay. Cell Notes 2005;13:8-10
   Google Scholar
• Cali JJ. Screen for CYP450 inhibitors using P450-Glo luminescent cytochrome P450 assays. Cell Notes 2003;7:2-4
   Web of Science ®Google Scholar
• Donato MT, Gomez-Lechon MJ, Castell JV. A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Bioch 1993;213:29-33
   PubMed Web of Science ®Google Scholar
• Donato MT, Jimenez N, Castell JV, Gomez-Lechon MJ. Fluorescent-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 2004;32(7):699-706
   PubMed Web of Science ®Google Scholar
• Parkinson A. Biotransformation of xenobiotics. In: Casarett & Doull's Toxicology, the Basic Science of Poisons, Sixth edition. Klaassen CD (Ed.), The McGraw-Hill Companies Inc.; 2001. p. 133-224.
   Google Scholar
• Dams R, Benijts TH, Lambert WE, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication, J Anal Toxicol 2001;25:147-51
   PubMed Web of Science ®Google Scholar
• Gnerre C, Kosel M, Baumann P, Carrupt PA, Testa B. Interaction of psychotropic drugs with monoamine oxidase in rat brain. J Pharm Pharmacol 2001;53:1125-30
   PubMed Web of Science ®Google Scholar
• Benedetti MS, Whomsley R, Baltes E. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opin Drug Metab Toxicol 2006;2(6):895-921
   PubMed Web of Science ®Google Scholar
• Technical Resources, Promega Corp. website, see MAO-Glo Assay, Technical Bulletin 345. Available at: URL: www.promega.com [Accessed August 2007]
   Google Scholar
• Technical Resources, Promega Corp. website, see Apo-ONE Homogeneous Caspase-3/7 Assay, Technical Bulletin 295 and 323. Available at: URL: www.promega.com [Accessed August 2007]
   Google Scholar
• Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Bioch 1997;253(2):162-8
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88
   PubMed Web of Science ®Google Scholar
• Josephy PD. The molecular toxicology of acetaminophen. Drug Metab Rev 2005;37(4):581-94
   PubMed Web of Science ®Google Scholar
• Guo GL, Moffit JS, Nicol CJ, et al. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci 2004;82:374-80
   PubMed Web of Science ®Google Scholar
• Senft AP, Dalton TP, Shertzer HG. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal Bioch 2000;280:80-6
   PubMed Web of Science ®Google Scholar
• Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Meth Enz 1981;77:373-82
   PubMedGoogle Scholar
• Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007;14:32-43
   PubMed Web of Science ®Google Scholar
• White EH, Worther H, Seliger HH, McElroy WD. Amino analogues of firefly luciferin and biological activity thereof. J Am Chem Soc 1966;88(9):2015-19
   Web of Science ®Google Scholar
• Monsees T, Miska W, Geiger R. Synthesis and characterization of a bioluminogenic substrate for alpha-chymotrypsin. Anal Biochem 1994;221:329-34
   PubMed Web of Science ®Google Scholar
• Monsees T, Geiger R, Miska W. A novel bioluminogenic assay for alpha-chymotrypsin. J Biolumin Chemilumin 1995;10:213-18
   PubMedGoogle Scholar
• O'Brien M, Moravec R, Riss T. Caspase-glo 3/7 assay: use fewer cells and spend less time with this homogeneous assay. Cell Notes 2003;6:13-15
   Google Scholar
• O'Brien MA. A comparison of homogeneous bioluminescent and fluorescent methods for protease assays. In: Handbook of Assay Development in Drug Discovery. Minor LK (Ed.), Taylor and Francis; 2006. p. 125-39
   Google Scholar
• Ekwall B, Clemedson C, Barile FA, et al. MEIC evaluation of acute systemic toxicity: Part VI. Prediction of human toxicity by rodent LD50 values and results from 61 in vitro tests. ATLA 1998;26:617-58
   Google Scholar
• Riss TL, Moravec RA, O'Brien MA, Hawkins EM, Niles A. Homogeneous multiwell assays for measuring cell viability, cytotoxicity and apoptosis. In: Handbook of Assay Development in Drug Discovery. Minor LK (Ed.), Taylor and Francis; 2006. p. 385-406
   Google Scholar
• Riss TL, Moravec RA. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Devel Tech 2004;2(1):51-62
   PubMed Web of Science ®Google Scholar
• Niles A, Moravec R, Hesselberth P, Scurria M, Daily W, Riss T. A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. J Anal Biochem 2007;366:197-206
   PubMed Web of Science ®Google Scholar
• Niles A, Worzela T, Scurria M, et al. Multiplexed viability, cytotoxicity and apoptosis assays for cell-based screening. Cell Notes 2006;16:12-15
   Google Scholar
• Squirrel D, Murphy J. Rapid detection of very low number of micro-organisms using adenylate kinase as a cell marker. A Practical Guide to Industrial Uses of ATP Luminescence in Rapid Microbiology; 1997. p. 107-13
   Google Scholar
• Corey MJ, Kinders R, Brown L, Vessella R. A very sensitive coupled luminescent assay for cytotoxicity and complement-mediated lysis. J Immuno Methods 1997;207:43-51
   PubMed Web of Science ®Google Scholar
• ToxiLight BioAssay Kit, instructions for use. Available at: URL: http://www.lonzabioscience.com/Content/Documents/Bioscience/ToxiLight18882-0705-01.pdf [Accessed August, 2007]
   Google Scholar
• aCella-Tox Bioluminescent Cytotoxicity Assay. Assay protocol. Available at: URL: http://www.celltechnology.com/documents/protocols/aCella-TOX%20v1_2.pdf [Access August 2007
   Google Scholar
• Niles A, Scurria M, Bernad L, et al. Measure relative numbers of live and dead cells and normalize assay data to cell number. Cell Notes 2007;18:15-20
   Web of Science ®Google Scholar
• Lundin A, Hasenson M, Persson J, Pousette A. Estimation of biomass in growing cell lines by ATP assay. Meth Enzymol 1986;133:27-42
   PubMed Web of Science ®Google Scholar
• Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Meth 1993;160:81-8
   PubMed Web of Science ®Google Scholar
• Kangas L, Gronoos M Nieminen A-L. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 1984;62:338-43
   PubMedGoogle Scholar
• Ma D, Cali JJ. Identify P-glycoprotein substrates and inhibitors with the rapid, HTS Pgp-glo assay system. Promega Notes 2007;96:11-14
   Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular and pharmacological aspects of the multidrug transporter. Ann Rev Pharmacol Toxicol 1999;39:361-98
   PubMed Web of Science ®Google Scholar
• Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004;1:27-42
   PubMedGoogle Scholar
• Scarborough GA. Drug-stimulated ATPase activity of the human P-glycoprotein. J Bioen Biomemb 1995;27(1):37-41
   PubMed Web of Science ®Google Scholar
• Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992;267(7):4854-8
   PubMed Web of Science ®Google Scholar
• Saheki S, Takeda A, Shimazu T. Assay of inorganic phosphate in the mild pH range, suitable for measurement of glycogen phosphorylase activity. Anal Bioch 1985;148:277-81
   PubMed Web of Science ®Google Scholar
• Drueckes P, Schinzel R, Palm D. Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal Bioch 1995;230:173-7
   PubMed Web of Science ®Google Scholar
• Wang EJ, Casciano CN, Clement RP, Johnson WW. Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. Bioch Bioph Res Commun 2001;289(2):580-5
   PubMed Web of Science ®Google Scholar
• Feng RL, Paranjpe PV, Guo A, Rubin E, Sinko P. Intestinal transport of irinotecan in caco-2 cells and mdck II cells overexpressing efflux transporters PGP, CMOAT, and MRP1. Drug Metab Dispos 2002;30(7):763-70
   PubMed Web of Science ®Google Scholar
• Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Devel Tech 2007;5(1):127-36
   PubMed Web of Science ®Google Scholar
• Sinz M, Kim S, Zhu Z, et al. Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions. Curr Drug Metab 2006;7:375-88
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Guidance for industry. Drug Interaction studies-studt design, data analysis and implications for dosing and labeling. Available at: URL: http://www.fda.gov/cder/guidance/2635fnl.pdf [Accessed August 2007]
   Google Scholar
• Dixit V, Hariparsad N, Li F, Desai P, Thummel KE, Unadkat JD. Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions. Drug Metab Dispos 2007;35:1853-9
   PubMedGoogle Scholar
• Paguio A, Almomd B, Fan F, et al. pGL4 vectors: a new generation of luciferase reporter vectors. Promega Notes 2005;89:7-10
   Google Scholar
• Kent TC, Thompson KSJ, Naylor LH. Development of a generic dual-reporter gene assay for screening G-protein-coupled receptors. J Biomol Screen 2005;10:437-46
   PubMed Web of Science ®Google Scholar
• Wood K. Choosing the right luciferase to light your way. Cell Notes 2004;8:2-6
   Web of Science ®Google Scholar
• Almond BD, Zdanovsky A, Zdanovskaia M, et al. Introducing the rapid response reporter vectors. Promega Notes 2004;87:18-22
   Google Scholar
• Grant SK, Sklar JG, Cummings RT. Development of novel assays for proteolytic enzymes using rhodamine-based fluorogenic substrates. J Biomol Screen 2002;7(6):531-40
   PubMed Web of Science ®Google Scholar
• Pichler A, Prior JL, Piwnica-Worms D. Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci USA 2004;101(6):1702-7
   PubMed Web of Science ®Google Scholar
• Wood KV, Lam YA, Seliger HH, McElroy WD. Complementary DNA coding click beetle luciferases can elicit bioluminescence of different colors. Science 1989;244:700-2
   PubMed Web of Science ®Google Scholar
• Shimomura O, Johnson FH, Saiga Y. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea J Cell Comp Physiol 1962;59:223-39
   PubMedGoogle Scholar
• Lepoul E, Hisada S, Mizuguchi Y, Dupriez VJ, Burgeon E, Detheux M. Adaptaion of aequorin functional assay to high throughput screening. J Biomol Screen 2002;7:57-65
   PubMed Web of Science ®Google Scholar